THOMAS JEFFERSON UNIV. HOSPITAL
1. Target Overview & Investment Thesis
THOMAS JEFFERSON UNIV. HOSPITAL is a 868-bed large academic medical center in PHILADELPHIA, PA with $1.93B in net patient revenue and a -23.1% operating margin. The hospital serves a payer mix of 24.1% Medicare, 4.5% Medicaid, and 71.4% commercial.
Thesis: Undervalued. Our ML models identify $142.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -23.1% to -15.7% (+736bps).
| Net Revenue HCRIS | $1.93B |
| Current EBITDA COMPUTED | $-445.5M |
| Operating Margin COMPUTED | -23.1% |
| Occupancy HCRIS | 73.3% |
| Revenue / Bed COMPUTED | $2.2M |
| Net-to-Gross HCRIS | 27.4% |
| Distress Probability ML | 43.5% |
2. Market Context & Competitive Position
PA has 225 Medicare-certified hospitals with a median operating margin of -4.4%. The target's margin of -23.1% places it below the state median. Among 16 size-comparable peers (434-1736 beds), the median margin is -2.7%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (434-1736), prioritizing same-state peers. 16 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| THOMAS JEFFERSON UNIV. HOSPITA (Target) | PA | 868 | $1.93B | -23.1% |
| ST. LUKES HOSPITAL | PA | 633 | $8.94B | 87.9% |
| HOSPITAL OF THE UNIV OF PENNA | PA | 1051 | $3.36B | -12.8% |
| LEHIGH VALLEY | PA | 1190 | $2.84B | -5.9% |
| THE CHILDRENS HOSPITAL OF PHIL | PA | 667 | $2.70B | -26.8% |
| UPMC - PRESBYTERIAN SHADYSIDE | PA | 1141 | $2.24B | -23.0% |
| MILTON S. HERSHEY MEDICAL CENT | PA | 616 | $2.08B | -2.8% |
| TEMPLE UNIVERSITY HOSPITAL | PA | 761 | $1.99B | 0.8% |
| GEISINGER MEDICAL CENTER | PA | 525 | $1.58B | 4.1% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $142.2M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $40.6M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $38.6M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $38.3M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $23.5M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $1.2M | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-445.5M |
| + RCM Uplift | +$142.2M |
| Pro Forma EBITDA | $-303.3M |
| Current Margin | -23.1% |
| Pro Forma Margin | -15.7% |
| WC Released (1x) | $74.1M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-685.4M | $-1.52B | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-685.4M | $-1.89B | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-616.8M | $-1.64B | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-616.8M | $-1.98B | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-753.9M | $-2.00B | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-753.9M | $-2.45B | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 16 hospitals with 434-1736 beds
- Same-state prioritization (n=17)
- Comp margins: P25=-11.4% / P50=-2.7% / P75=4.6%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.